The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system.
Bhimani J, O'Connell K, Persaud S, Blinder V, Burganowski RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED.
Bhimani J, et al. Among authors: griggs jj.
Breast Cancer Res Treat. 2024 Nov;208(2):405-414. doi: 10.1007/s10549-024-07433-4. Epub 2024 Aug 16.
Breast Cancer Res Treat. 2024.
PMID: 39150586